Chemistry: molecular biology and microbiology – Vector – per se
Patent
1996-05-30
1999-12-21
Housel, James C.
Chemistry: molecular biology and microbiology
Vector, per se
4242441, C12N 1500, A61K 3909
Patent
active
060048026
ABSTRACT:
Oral or peroral administration, including intragastrically, of killed whole pneumococci, lysate of pneumococci and isolated and purified PspA, as well as immunogenic fragments thereof, particularly when administered with an adjuvant such as cholera toxin provides protection in a host, animal or human, against pneumococcal infection, including colonization, and systemic infection, such as sepsis. The ability to elicit protection against pneumococcal colonization in a host prevents carriage among immunized individuals, which can lead to elimination of disease from the population as a whole.
REFERENCES:
patent: 4873090 (1989-10-01), Clancy
patent: 5476929 (1995-12-01), Briles et al.
Yothen et al Abstracts of the General Meeting of American Soc. for Microbiology p. 127 D-189, 1992.
Germie et al Novel Vaccine Strategies Mucosal Immunization, Adjuvants & Genetic Approaches Oct. 1993, Abstract.
Yoshimura et al Abstracts of the Fifth International Symposium Recent Advances in Otitis Media, p. 73 Abst. #77, 1991.
van de Wijgent et al Infection and Immunity 59:2750-27, 1991.
Yother et al Journal of Bacteriology 174:610-610 1992.
Kuromo et al Abstracts of the Fourteenth Midwinter Research Meeting Assoc. for Resin Otol. p. 56 190 178, 19.
McDaniel et al Infection and Immunity 59:222-228, 1991.
Briles David E.
Kiyono Hiroshi
McDaniel Larry S.
Yamamoto Masafumi
Frommer William S.
Housel James C.
Kowalski Thomas J.
Swartz Rodney P.
University of Alabama at Birmingham
LandOfFree
Oral administration of pneumococcal antigens does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Oral administration of pneumococcal antigens, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Oral administration of pneumococcal antigens will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-504051